A Phase 2 trial of AR301 in walnut allergy

Next Previous
Trial Profile

A Phase 2 trial of AR301 in walnut allergy

Planning
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2018

At a glance

  • Drugs AR 301 (Primary)
  • Indications Food hypersensitivity
  • Focus Therapeutic Use

    • Most Recent Events

    • 16 Mar 2018 New trial record
    • 12 Mar 2018 According to an Aimmune Therapeutics media release, the company is planning to start this trial in 2H 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top